Professor Adam Guastella is the Michael Crouch Chair in Child and Youth Mental Health. His position is based at both Sydney Children’s Hospital at Westmead and the Brain and Mind Centre, University of Sydney. His work aims to build collaborative partnerships between researchers, clinicians, and services to ensure that children and families receive the best available assessments and treatments to support well-being. As part of this role, he is the co-lead of the Child-Neurodevelopment and Mental Health Team for the University of Sydney. This team aims to solve complex problems for children with neurodevelopmental disorders and their families with a team of multi-disciplinary professors across the university. He is also the co-lead for the child bio-informatics hub for the University of Sydney, applying technology application to support well-being and research with families.
Adam Guastella
Professor
Brain and Mind Centre; Children’s Hospital Westmead Clinical School
From this contributor
To accelerate the study of neurodevelopment, we need a transdiagnostic framework
Our tendency to focus on one condition at a time likely silos expertise and services—and obscures critical connections across diagnostic categories.
To accelerate the study of neurodevelopment, we need a transdiagnostic framework
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.